Publication List

Agramunt, S. and Lenton, S. (2021). Characteristics of PWID who are in treatment versus not in treatment: COVID-19 related health concerns and behaviours. Findings from the Illicit Drug Reporting System 2020. National Drug and Alcohol Research Centre, UNSW.

Alexeev, S., & Weatherburn, D. (2021). The Australian ready-to-drink beverages tax missed its target age group. International Journal of Drug Policy, 95. doi:10.1016/j.drugpo.2021.103399

Asare-Doku, W., Rich, J. L., Kelly, B., Amponsah-Tawiah, K., & James, C. (2021). Mental health and mining: the Ghanaian gold mining story. International Archives of Occupational and Environmental Health, 94(6), 1353-1362. doi:10.1007/s00420-021-01726-7

Ayano, G., Lin, A., Dachew, B.A., Tait, R.J., Betts, K. and Alati, R. (2021). The impact of parental mental health problems on the educational outcomes of their offspring: Findings from the Raine Study. Australian and New Zealand Journal of Psychiatry. DOI: http://dx.doi.org/10.1177/00048674211025633

Beck, A. K., Larance, B., Deane, F. P., Baker, A. L., Manning, V., Hides, L., . . . Kelly, P. J. (2021). The use of Australian SMART Recovery groups by people who use methamphetamine: Analysis of routinely-collected nationwide data. Drug and Alcohol Dependence, 225. doi:10.1016/j.drugalcdep.2021.108814

Berridge, V., Hall, W., & Gartner, C. (2021). Response to Daube & Chapman. Addiction, 116(9), 2588-2589. doi:10.1111/add.15499

Berridge, V., Hall, W., Taylor, S., Gartner, C., & Morphett, K. (2021). A first pass, using pre-history and contemporary history, at understanding why Australia and England have such different policies towards electronic nicotine delivery systems, 1970s–c. 2018. Addiction, 116(9), 2577-2585. doi:10.1111/add.15391

Biden, E. J., Greenwood, C. J., Macdonald, J. A., Spry, E. A., Letcher, P., Hutchinson, D., . . . Olsson, C. A. (2021). Preparing for Future Adversities: Lessons From the COVID-19 Pandemic in Australia for Promoting Relational Resilience in Families. Front Psychiatry, 12, 717811. doi:10.3389/fpsyt.2021.717811

Bonsaksen, T., Leung, J., Schoultz, M., Thygesen, H., Price, D., Ruffolo, M., & Geirdal, A. O. (2021). Cross-National Study of Worrying, Loneliness, and Mental Health during the COVID-19 Pandemic: A Comparison between Individuals with and without Infection in the Family. Healthcare, 9(7). doi:10.3390/healthcare9070903

Bonsaksen, T., Ruffolo, M., Leung, J., Price, D., Thygesen, H., Schoultz, M., & Geirdal, A. Ø. (2021). Loneliness and Its Association With Social Media Use During the COVID-19 Outbreak. Social Media + Society, 7(3), 205630512110338-205630512110338. doi:10.1177/20563051211033821

Brothers, T. D., Kaulbach, J., & Tran, A. (2021). Unhealthy alcohol use in a 65-year-old man awaiting surgery. CMAJ, 193(32), E1250-E1252. doi:10.1503/cmaj.202128

Brothers, T. D., Lewer, D., Bonn, M., Webster, D., & Harris, M. (2021). Social and structural determinants of injecting-related bacterial and fungal infections among people who inject drugs: Protocol for a mixed studies systematic review. BMJ Open, 11(8). doi:10.1136/bmjopen-2021-049924

Brothers, T. D., Lewer, D., & Thakrar, A. P. (2021). Linking opioid use disorder treatment from hospital to community. Addiction, 116(8), 2244-2245. doi:10.1111/add.15460

Bruno, R. (2021). Use of commercial filters among a sample of people who regularly inject drugs: Findings from the Illicit Drug Reporting System 2016-2020. Retrieved from Sydney:

Bruno, R., Huxley, L., Wilson, T., & Ye, L. (2021). Have we seen a change in psychedelic use among people who regularly use ecstasy and other illicit stimulants? Retrieved from https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/Psychedelics%20Bulletin_2021_TAS_FINAL_0.pdf

Butler, T., Schofield, P. W., Knight, L., Ton, B., Greenberg, D., Scott, R. J., . . . Carr, V. (2021). Sertraline hydrochloride for reducing impulsive behaviour in male, repeat-violent offenders (ReINVEST): protocol for a phase IV, double-blind, placebo-controlled, randomised clinical trial. BMJ Open, 11(9), e044656. doi:10.1136/bmjopen-2020-044656

Caluzzi, G., Livingston, M., Holmes, J., MacLean, S., Lubman, D., Dietze, P., Vashishtha, R., Herring, R. and Pennay, A. (2021). Declining drinking among adolescents: Are we seeing a denormalisation of drinking and a normalisation of non-drinking? Addiction. DOI: http://dx.doi.org/10.1111/add.15611

Champion, K.E., Chapman, C., Gardner, L.A., Sunderland, M., Newton, N.C., Smout, S., Thornton, L., Hides, L., McBride, N., Allsop, S., Mills, K., Kay-Lambkin, F.J., Teesson, M., Slade, T. and Health4Life Team. (2021). Profiling the Big 6 lifestyle risk behaviours for chronic disease: A cross-sectional survey among Australian adolescents. Medical Journal of Australia. [In Press]

Chan, G. C. K., Stjepanović, D., Lim, C., Sun, T., Shanmuga Anandan, A., Connor, J. P., . . . Leung, J. (2021). A systematic review of randomized controlled trials and network meta-analysis of e-cigarettes for smoking cessation. Addictive Behaviors, 119. doi:10.1016/j.addbeh.2021.106912

Charles, H., Heron, J., Hickman, M., Brown, J., & Hines, L. (2021). Testing the validity of national drug surveys: comparison between a general population cohort and household surveys. Addiction, 116(8), 2076-2083. doi:10.1111/add.15371

Charlson, F., Gynther, B., Obrecht, K., Heffernan, E., David, M., Young, J.T. and Hunter, E. (2021). Incarceration among adults living with psychosis in Indigenous populations in Cape York and the Torres Strait. Australian and New Zealand Journal of Psychiatry, 55, (7). DOI: http://dx.doi.org/10.1177/0004867420985247

Chikritzhs, T.N. and Livingston, M. (2021). Alcohol and the risk of injury. Nutrients, 13, (8). DOI: http://dx.doi.org/10.3390/nu13082777

Chiu, V., Leung, J., Hall, W., Stjepanović, D., & Degenhardt, L. (2021). Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA. Neuropharmacology, 193. doi:10.1016/j.neuropharm.2021.108610

Choi, S. K. Y., Tran, D. T., Kemp-Casey, A., Preen, D. B., Randall, D., Einarsdottir, K., . . . Havard, A. (2021). The Comparative Effectiveness of Varenicline and Nicotine Patches for Smoking Abstinence During Pregnancy: Evidence From a Population-based Cohort Study. Nicotine Tob Res, 23(10), 1664-1672. doi:10.1093/ntr/ntab063

Chu, A. L., Hickman, M., Steel, N., Jones, P. B., Davey Smith, G., & Khandaker, G. M. (2021). Inflammation and Depression: A Public Health Perspective. Brain, Behavior, and Immunity, 95, 1-3. doi:10.1016/j.bbi.2021.04.015

Clare, P., Aiken, A., Yuen, W., Upton, E., Degenhardt, L., Bruno, R., McCambridge, J., McBride, N., Hutchinson, D., Slade, T., Mattick, R. and Peacock, A. (2021). Alcohol use among young Australian adults in May-June 2020 during the COVID-19 pandemic: a prospective cohort study. Addiction. DOI: http://dx.doi.org/10.1111/add.15599

Clay, S. (2021). A Queer Account of Self-Care - Autopoiesis Through Auto-Annihilation. Whatever: A Transdisciplinary Journal of Queer Theories and Studies, 4, 672-676. Retrieved from https://whatever.cirque.unipi.it/index.php/journal/article/view/151

Cohen, J., Alvestad, S., Suarez, E., Schaffer, A., Selmer, R., Havard, A., . . . Furu, K. (2021). The Comparative Safety of Antiseizure Medication Polytherapy vs Valproate in Pregnancy and Risk of Major Congenital Malformations. In International Conference on Pharmacoepidemiology and Therapeutic Risk Management. Virtual: John Wiley and Sons.

Conway, A., Valerio, H., Peacock, A., Degenhardt, L., Hayllar, J., Harrod, M., Henderson, C., Read, P., Gilliver, R., Christmass, M., Dunlop, A., Montebello, M., Whitton, G., Lam, T., Alavi, M., Silk, D., Marshall, A., Treloar, C., Dore, G.J. and Grebely, J. (2021). Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study. International Journal of Drug Policy. DOI: http://dx.doi.org/10.1016/j.drugpo.2021.103421

Corcoran, E., Lewis, G., Heron, J., Hickman, M., & Lewis, G. (2021). COGNITIVE STYLE AND DRINKING TO COPE: A PROSPECTIVE COHORT STUDY. Addiction. doi:10.1111/add.15655

Courtney, R. J., McRobbie, H., Tutka, P., Weaver, N. A., Petrie, D., Mendelsohn, C. P., . . . Farrell, M. (2021). Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial. JAMA - Journal of the American Medical Association, 326(1), 56-64. doi:10.1001/jama.2021.7621

de Castro Amato, T., Opaleye, E., McBride, N. and Noto, A. (2021). Reducing alcohol-related risks among adolescents: a feasibility study of the SHAHRP program in Brazilian schools. Ciencia & Saude Coletiva, 26, (8), pp. 3005-3018. DOI: http://dx.doi.org/10.1590/1413-81232021268.13472020

Duko, B., Pereira, G., Tait, R.J., Nyadanu, S.D., Betts, K. and Alati, R. (2021). Prenatal Tobacco Exposure and the Risk of Tobacco Smoking and Dependence in Offspring: a Systematic Review and Meta-analysis. Drug and Alcohol Dependence, 227. DOI: http://dx.doi.org/10.1016/j.drugalcdep.2021.108993

Evelyn, L., Limin, M., John, D. W., John, R., Andrew, C., Krista J, S., & investigators, P. s. (2021). Impact of the removal of patient co-payments for antiretroviral therapy (ART) on out-of-pocket expenditure, adherence and virological failure among Australian adults living with HIV. Health Policy. doi:10.1016/j.healthpol.2021.07.002

Fisher, H., Evans, K., Reynolds, R., Yates, J., Roderick, M., Ferrie, J., . . . Audrey, S. (2021). Secondary analyses to test the impact on inequalities and uptake of the schools-based human papillomavirus (HPV) vaccination programme by stage of implementation of a new consent policy in the south-west of England. BMJ Open, 11(7). doi:10.1136/bmjopen-2020-044980

Fischer, J. A., & Lang, R. (2021). Alcohol and Other Drugs National Quality Framework Mapping Standards Refresh. Adelaide, South Australia: NCETA, Flinders University and Queensland Network of Alcohol and Other Drug Agencies Ltd (QNADA).

Freeburn, B., Loggins, S., Lee, K.S. and Conigrave, K. (2021). Coming of age: 21 years of providing opioid substitution treatment within an Aboriginal community-controlled primary health service. Drug and Alcohol Review. DOI: http://dx.doi.org/10.1111/dar.13345

Furneaux-Bate, A., Newton, N.C., Birrell, L., Slade, T., Chapman, C., Healy, A., Mewton, L., Hides, L., McBride, N., Allsop, S., Chatterton, M.L. and Teesson, M. (2021). School-based prevention for depression, anxiety, and substance use: effectiveness and long-term follow-up of the climate schools combined study. International Journal of Behavioral Medicine. DOI: http://dx.doi.org/WOS:000660029800008

Gilmore, W. and Gilmore, I. (2021). Alcohol and men's health. In Kirby, R., Carson, C., White, A. and Kirby, M. (eds.) Men's Health (4th ed). CRC Press (Taylor & Francis Group), London. ISBN: 9780367360788

Goutzamanis, S., Spelman, T., Harney, B., Dietze, P., Stoove, M., Higgs, P., . . . Hellard, M. (2021). Patient-reported outcomes of the Treatment and Prevention Study: A real-world community-based trial of direct-acting antivirals for hepatitis C among people who inject drugs. Journal of Viral Hepatitis, 28(7), 1068-1077. doi:10.1111/jvh.13516

Greenwood, C. J., Youssef, G. J., Fuller-Tyszkiewicz, M., Letcher, P., Macdonald, J. A., Hutchinson, D. M., . . . Olsson, C. A. (2021). Psychosocial predictors of binge-drinking residual harm in adolescence and young adulthood: Findings from the Australian Temperament Project. Drug and Alcohol Dependence, 226. doi:10.1016/j.drugalcdep.2021.108864

Hajarizadeh, B., Grebely, J., Byrne, M., Marks, P., Amin, J., McManus, H., . . . Willenborg, C. (2021). Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study. The Lancet Gastroenterology and Hepatology, 6(7), 533-546. doi:10.1016/S2468-1253(21)00077-7

Hall, W., & Gartner, C. (2021). Australian policymakers do not have to choose between protecting youth and allowing smokers to use nicotine vaping products. Addiction, 116(9), 2257-2259. doi:10.1111/add.15512

Haregu, T., Jorm, A.F., Paradies, Y., Leckning, B. and Young, J.T. (2021). Discrimination experienced by Aboriginal and Torres Strait Islander males in Australia: Associations with suicidal thoughts and depressive symptoms. Australian and New Zealand Journal of Psychiatry. [In Press] DOI: http://dx.doi.org/10.1177/00048674211031168

Haroutounian, S., Arendt-Nielsen, L., Belton, J., Blyth, F. M., Degenhardt, L., Di Forti, M., . . . Rice, A. S. C. (2021). International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management. Pain, 162, S117-S124. doi:10.1097/j.pain.0000000000002266

Hazeldine, S., Davies, I., Tait, R.J. and Olynyk, J. (2021). Critical role of general practitioners in preventing readmission following emergency department alcohol screening and brief intervention management of alcohol-related problems, 12. DOI: http://dx.doi.org/10.1177/21501327211027437

Heerde, J.A., Patton, G., Young, J.T., Borschmann, R. and Kinner, S.A. (2021). Homelessness and the right to life. Parity, 34, (7), pp. 22-24. [In Press]

Hickman, M. J., Strote, J. N., Scales, R. M., Parkin, W. S., & Collins, P. A. (2021). Police Use of Force and Injury: Multilevel Predictors of Physical Harm to Subjects and Officers. Police Quarterly, 24(3), 267-297. doi:10.1177/1098611120972961

Jackson, M. A., Baker, A. L., Gould, G. S., Brown, A. L., Dunlop, A. J., & McCarter, K. (2021). Smoking cessation interventions for pregnant women attending treatment for substance use disorders: A systematic review. Addiction. doi:10.1111/add.15663

Jackson, M. A., Brown, A. L., Johnston, J., Clancy, R., McGregor, I., Bruno, R., . . . Dunlop, A. J. (2021). The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients. J Cannabis Res, 3(1), 33. doi:10.1186/s42238-021-00091-z

Kelly, P. J., McCreanor, K., Beck, A. K., Ingram, I., O'Brien, D., King, A., . . . Larance, B. (2021). SMART Recovery International and COVID-19: Expanding the reach of mutual support through online groups. Journal of Substance Abuse Treatment(108568), 108568-108568. doi:10.1016/j.jsat.2021.108568

Lam, T., Hayman, J., Berecki-Gisolf, J., Sanfilippo, P., Lubman, D. I., & Nielsen, S. (2021). Pharmaceutical opioid poisonings in Victoria, Australia: rates and characteristics of a decade of Emergency Department presentations across nine pharmaceutical opioids. Addiction. doi:10.1111/add.15653

Lam, T., Laslett, A.L., Fischer, J., Salom, C.L., Ogeill, R., Lubman, D., Aiken, A., Mattick, R., Gilmore, W. and Allsop, S. (2021). Disclosures of harming others during their most recent drinking session: Findings from a large national study of heavy-drinking adolescents. Drug and Alcohol Review. DOI: http://dx.doi.org/10.1111/dar.13336

Lamy, F. R., Daniulaityte, R., Barratt, M. J., Lokala, U., Sheth, A., & Carlson, R. G. (2021). “Etazene, safer than heroin and fentanyl”: Non-fentanyl novel synthetic opioid listings on one darknet market. Drug and Alcohol Dependence, 225. doi:10.1016/j.drugalcdep.2021.108790

Lappin, J. M., & Darke, S. (2021). Methamphetamine and heightened risk for early-onset stroke and Parkinson's disease: A review. Experimental Neurology, 343. doi:10.1016/j.expneurol.2021.113793

Laslett, A.L. and Room, R. (2021). Using registry data to better understand alcohol's harm to others. Journal of Studies on Alcohol and Drugs, 82, (4), pp. 457-459. DOI: http://dx.doi.org/10.15288/jsad.2021.82.457

Laslett, A.L., Jiang, H. and Room, R. (2021). Minimum unit price deters heaviest alcohol purchasers. The Lancet Public Health, 6, (8), pp. e535-e536. DOI: http://dx.doi.org/10.1016/S2468-2667 (21)00095-5

Laslett, A.L., Mojica-Perez, Y., Waleewong, O., Hanh, H.T. and Jiang, H. (2021). Harms to children from the financial effects of others' drinking. International Journal of Drug Policy, 94. DOI: http://dx.doi.org/10.1016/j.drugpo.2021.103254

Leggat, G., Livingston, M., Kuntsche, S. and Callinan, S. (2021). Changes in alcohol consumption during pregnancy and over the transition towards parenthood. Drug and Alcohol Dependence, 225. DOI: http://dx.doi.org/10.1016/j.drugalcdep.2021.108745

Lenton, S., & Agramunt, S. (2021). Characteristics of PWID who are in treatment versus not in treatment: COVID 19 related health concerns and behaviours. Findings from the WA Illicit Drug Reporting System 2020. Retrieved from https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/WA_2020_IDRS_Characteristics%20of%20PWID_COVID%20health%20concerns_0.pdf

Lewer, D., Menezes, D., Cornes, M., Blackburn, R. M., Byng, R., Clark, M., . . . Aldridge, R. (2021). Hospital readmission among people experiencing homelessness in England: A cohort study of 2772 matched homeless and housed inpatients. Journal of Epidemiology and Community Health, 75(7), 681-688. doi:10.1136/jech-2020-215204

Lim, C. C. W., Leung, J., Chung, J. Y. C., Sun, T., Gartner, C., Connor, J., . . . Chan, G. (2021). Content analysis of cannabis vaping videos on YouTube. Addiction, 116(9), 2443-2453. doi:10.1111/add.15424

Litherland, S., Miller, P.G., Droste, N. and Graham, K. (2021). Male Barroom Aggression among Members of the Australian Construction Industry: Associations with Heavy Episodic Drinking, Trait Variables and Masculinity Factors. International Journal of Environmental Research and Public Health, 18, (13). DOI: http://dx.doi.org/10.3390/ijerph18136769

Man, N., Chrzanowska, A., Sutherland, R., Degenhardt, L., & Peacock, A. (2021). Trends in drug-related hospitalisations in Australia, 1999-2019 (978-0-7334-3989-6). Retrieved from https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/Drug%20Related%20Hospitalisations%201999-2019.pdf

McEntee, A., Kim, S., Harrison, N., Chapman, J., & Roche, A. (2021). Patterns and Prevalence of Daily Tobacco Smoking in Australia by Industry and Occupation: 2007–2016. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntab126

McIntosh, J. E., Olsson, C. A., Schuijers, M., Tan, E. S., Painter, F., Schnabel, A., . . . Hutchinson, D. (2021). Exploring Perinatal Indicators of Infant Social-Emotional Development: A Review of the Replicated Evidence. Clinical Child and Family Psychology Review, 24(3), 450-483. doi:10.1007/s10567-021-00356-2

McKetin, R., Dean, O. M., Turner, A., Kelly, P. J., Quinn, B., Lubman, D. I., . . . Berk, M. (2021). N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial. EClinicalMedicine, 38. doi:10.1016/j.eclinm.2021.101005

McRobbie, H., Boland, V. C., & Courtney, R. J. (2021). Assessing cannabis and tobacco co-use: the pros and cons of additional data collection. Addiction, 116(7), 1631-1633. doi:10.1111/add.15373

McRobbie, H., & Kwan, B. (2021). Tobacco use disorder and the lungs. Addiction, 116(9), 2559-2571. doi:10.1111/add.15309

Marynowski-Traczyk, D., Wallis, M., Broadbent, M., Scuffham, P., Young, J.T., Johnston, A.N., Fitzgerald, G., Heffernan, E., Kinner, S.A., Zang, P., Keijzers, G., Bosley, E., Martin-Khan, M., Shevlin, L. and Crilly, J. (2021). Optimising emergency department and acute care for people experiencing mental health problems: a nominal group study. Australian Health Review. [In Press]

Miller, M., Pettigrew, S. and Wright, C. (2021). Zero-alcohol beverages: Harm-minimisation tool or gateway drink? Drug and Alcohol Review. DOI: http://dx.doi.org/10.1111/dar.13359

Miller, P.G., Curtis, A., Millsteed, M., Harries, T., Nepal, S., Walker, S., Chikritzhs, T.N. and Coomber, K. (2021). Size does matter: An exploration of the relationship between licensed venue capacity and on-premise assaults. Alcoholism: Clinical and Experimental Research. DOI: http://dx.doi.org/10.1111/acer.14621

Ney, L. J., Felmingham, K. L., Bruno, R., Matthews, A., & Nichols, D. S. (2021). Chloroform-based liquid-liquid extraction and LC–MS/MS quantification of endocannabinoids, cortisol and progesterone in human hair. Journal of Pharmaceutical and Biomedical Analysis, 201. doi:10.1016/j.jpba.2021.114103

Nielsen, S., Sanfilippo, P. G., Scott, D., Lam, T., Smith, K., & Lubman, D. I. (2021). Characteristics of oxycodone-related ambulance attendances: analysis of temporal trends and the effect of reformulation in Victoria, Australia from 2013 to 2018. Addiction, 116(8), 2233-2241. doi:10.1111/add.15365

O'Brien, H., Di Rico, R., Dean, E., Smoker, G., Lloyd-Jones, M., McKechnie, M., Dietze, P. and Doyle, J.S. (2021). Screening for risky drinkers among hospitalised inpatients using the AUDIT: A feasibility, point prevalence and data linkage study. Drug and Alcohol Review. DOI: http://dx.doi.org/10.1111/dar.13343

Palmer, A. Y., Wilkinson, A., Aitken, C., Dietze, P., Dore, G. J., Maher, L., . . . Scott, N. (2021). Estimating the number of new hepatitis C infections in Australia in 2015, prior to the scale-up of direct-acting antiviral treatment. Journal of Gastroenterology and Hepatology (Australia), 36(8), 2270-2274. doi:10.1111/jgh.15485

Peacock, A., Gibbs, D., Price, O., Barratt, M. J., Ezard, N., Sutherland, R., . . . Bruno, R. (2021). Profile and correlates of colorimetric reagent kit use among people who use ecstasy/MDMA and other illegal stimulants in Australia. Int J Drug Policy, 97, 103334. doi:10.1016/j.drugpo.2021.103334

Pearce, L., Vaisey, A., Keen, C., Calais-Ferreira, L., Foulds, J., Young, J.T., Southalan, L., Borschmann, R., Gray, R., Sturup-Toft, S. and Kinner, S.A. (2021). A rapid review of early guidance to prevent and control COVID-19 in custodial settings. Health & Justice. [In Press]

Pettigrew, S., Booth, L., Jongenelis, M., Brennan, E., Chikritzhs, T.N., Hasking, P., Miller, P.G., Hastings, G. and Wakefield, M. (2021). A randomized controlled trial of the effectiveness of combinations of 'why to reduce' and 'how to reduce' alcohol harm-reduction communications. Addictive Behaviors, 121. DOI: http://dx.doi.org/10.1016/j.addbeh.2021.107004

Price, O., Dietze, P., Sullivan, S. G., Salom, C., & Peacock, A. (2021). Uptake, barriers and correlates of influenza vaccination among people who inject drugs in Australia. Drug and Alcohol Dependence, 226. doi:10.1016/j.drugalcdep.2021.108882

Price, O., Man, N., Bruno, R., Dietze, P., Salom, C.L., Lenton, S., Grigg, J., Gibbs, D., Wilson, T., Degenhardt, L., Chan, R., Thomas, N. and Peacock, A. (2021). Changes in illicit drug use and markets with the COVID-19 pandemic and associated restrictions: Findings from the Ecstasy and Related Drugs Reporting System, 2016-2020. Addiction. DOI: http://dx.doi.org/10.1111/add.15620

Seear, K., Fraser, S., Farrugia, A.C. and Valentine, K. (2021). Beyond a 'post-cure' world: Sketches for a new futurology of hepatitis C. International Journal of Drug Policy, 94. DOI: http://dx.doi.org/10.1016/j.drugpo.2020.103042

Sharwood, L.N., Wiseman, T., Tseris, E., Curtis, K., Vaikuntam, B., Craig, A. and Young, J.T. (2021). Pre-existing mental disorder, clinical profile, inpatient services, and costs in people hospitalised following traumatic spinal injury: a whole population record linkage study. Injury Prevention, 27, (3), pp. 238-244. DOI: http://dx.doi.org/10.1136/injuryprev-2019-043567

Siefried, K.J., Ezard, N., Christmass, M., Haber, P. and Ali, R.L. (2021). A clinical research priority setting study for issues related to the use of methamphetamine and emerging drugs of concern in Australia. Drug and Alcohol Review. DOI: http://dx.doi.org/10.1111/dar.13350

Sjodin, L., Livingston, M., Karlsson, P. and Raninen, J. (2021). Associations between trust and drinking among adolescents. Drug and Alcohol Review. DOI: http://dx.doi.org/10.1111/dar.13338

Skelton, E., Lum, A., Cooper, L. E., Barnett, E., Smith, J., Everson, A., . . . Bonevski, B. (2021). Addressing Smoking in Sheltered homelessness with Intensive Smoking Treatment (ASSIST Project): A pilot feasibility study of varenicline, combination nicotine replacement therapy and motivational interviewing. Addictive Behaviors(107074), 107074-107074. doi:10.1016/j.addbeh.2021.107074

Stearne, A. E., Allsop, S., Shakeshaft, A., Symons, M., & Wright, M. (2021). Identifying how the principles of self-determination could be applied to create effective alcohol policy for First Nations Australians: Synthesising the lessons from the development of general public policy. International Journal of Drug Policy, 93. doi:10.1016/j.drugpo.2021.103260

Sturgiss, E., Gunatillaka, N., Ball, L., Lam, T., Nielsen, S., O'Donnell, R., . . . Russell, G. (2021). Embedding brief interventions for alcohol in general practice: a study protocol for the REACH Project feasibility trial. BJGP Open, 5(4). doi:10.3399/BJGPO.2021.0037

Sutherland, R., Baillie, G., Peacock, A., Hammoud, M., Memedovic, S., Barratt, M., . . . Hughes, C. (2021). Key findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats (ADAPT)’ Study Wave 4. Retrieved from Sydney:

Sutherland, R., Uporova, J., & Peacock, A. (2021). Naloxone cascade of care among a sample of people who inject drugs in Canberra, ACT. Retrieved from Sydney:

Thomas, N., Daly, C., Juckel, J., Maravilla, J., & Salom, C. (2021). Trends in self-reported past year non-fatal overdose and responses to overdose: Findings from the Illicit Drug Reporting System. Retrieved from Sydney:

Treloar, C., Schroeder, S., Lafferty, L., Marshall, A., Drysdale, K., Higgs, P., . . . Dietze, P. (2021). Structural competency in the post-prison period for people who inject drugs: A qualitative case study. International Journal of Drug Policy, 95. doi:10.1016/j.drugpo.2021.103261

Van Den Boom, W., del Mar Quiroga, M., Fetene, D. M., Agius, P. A., Higgs, P. G., Maher, L., . . . Dietze, P. M. (2021). The Melbourne Safe Injecting Room Attracted People Most in Need of Its Service. American Journal of Preventive Medicine, 61(2), 217-224. doi:10.1016/j.amepre.2021.02.018

van Egmond, K., Wright, C., Livingston, M. and Kuntsche, E. (2021). A Parallel Test of the SCRAM-CAM Transdermal Monitors Ensuring Reliability. Drug and Alcohol Review. DOI: http://dx.doi.org/10.1111/dar.13353

Ward, N., Correia, H. and McBride, N. (2021). Maternal psycho-social risk factors associated with maternal alcohol consumption and Fetal Alcohol Spectrum Disorder: A systematic review. Archives of Gynecology and Obstetrics. DOI: http://dx.doi.org/10.1007/s00404-021-06206-4

Willoughby, M., Keen, C., Young, J.T., Spittal, M.J., Borschmann, R., Janca, E.K. and Kinner, S.A. (2021). Violence-related morbidity among people released from prison in Australia: A data linkage study. Drug and Alcohol Review. [In Press]

Yuen, W. S., Chan, G., Bruno, R., Clare, P. J., Aiken, A., Mattick, R., . . . Peacock, A. (2021). Trajectories of alcohol-induced blackouts in adolescence: early risk factors and alcohol use disorder outcomes in early adulthood. Addiction, 116(8), 2039-2048. doi:10.1111/add.15415

Zheng, C., Conigrave, J., Conigrave, K., Wilson, S., Perry, J., Chikritzhs, T.N., Fitts, M. and Lee, K.S. (2021). Patterns of drinking in Aboriginal and Torres Strait Islander peoples as self-reported on the Grog Survey App: A representative urban and remote sample. Drug and Alcohol Review. DOI: http://dx.doi.org/10.1111/dar.13333

Resources

Fischer, J. A., Roche, A. M., & Duraisingam, V. (2021). Alcohol Use Disorders Identification Test - Consumption (AUDIT-C): description, strengths and knowledge gaps. AOD Screening and Withdrawal Tools Collection. Adelaide, South Australia: National Centre for Education and Training on Addiction (NCETA), Flinders University.

Fischer, J. A., Roche, A. M., & Duraisingam, V. (2021). Alcohol Use Disorders Identification Test (AUDIT): description, strengths and knowledge gaps. AOD Screening and Withdrawal Tools Collection. Adelaide, South Australia: NCETA, Flinders University.

Fischer, J. A., Roche, A. M., & Duraisingam, V. (2021). Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): description, strengths and knowledge gaps. AOD Screening and Withdrawal Tools Collection. Adelaide, South Australia: NCETA, Flinders University.

Fischer, J. A., Roche, A. M., & Duraisingam, V. (2021). Alcohol, Smoking and Substance Involvement Screening Test (ASSIST-Lite) tool: description, strengths and knowledge gaps. AOD Screening and Withdrawal Tools Collection. Adelaide, South Australia: NCETA, Flinders University.

Fischer, J. A., Roche, A. M., & Duraisingam, V. (2021). Amphetamine Cessation Symptom Assessment (ACSA): description, strengths and knowledge gaps. AOD Screening and Withdrawal Tools Collection. Adelaide, South Australia: NCETA, Flinders University.

Fischer, J. A., Roche, A. M., & Duraisingam, V. (2021). Amphetamine Withdrawal Questionnaire (AWQ): description, strengths and knowledge gaps. AOD Screening and Withdrawal Tools Collection. Adelaide, South Australia: NCETA, Flinders University.

Fischer, J. A., Roche, A. M., & Duraisingam, V. (2021). AOD Screening and Withdrawal Tools Collection. AOD Screening and Withdrawal Tools Collection. Adelaide, South Australia: NCETA, Flinders University.

Fischer, J. A., Roche, A. M., & Duraisingam, V. (2021). Clinical Institute Withdrawal Assessment – Alcohol (CIWA-Ar): description, strengths and knowledge gaps. AOD Screening and Withdrawal Tools Collection.  Adelaide, South Australia: NCETA, Flinders University.

Fischer, J. A., Roche, A. M., & Duraisingam, V. (2021). AOD Screening and Withdrawal Tools Collection. AOD Screening and Withdrawal Tools Collection.  Adelaide, South Australia: NCETA, Flinders University.

Fischer, J. A., Roche, A. M., & Duraisingam, V. (2021). Clinical Opiate Withdrawal Scale (COWS): description, strengths and knowledge gaps. AOD Screening and Withdrawal Tools Collection. Adelaide, South Australia: NCETA, Flinders University.

Fischer, J. A., Roche, A. M., & Duraisingam, V. (2021). Cut down, Annoyed, Guilty and Eye-opener (CAGE): description, strengths and knowledge gaps. AOD Screening and Withdrawal Tools Collection. Adelaide, South Australia: NCETA, Flinders University.

Fischer, J. A., Roche, A. M., & Duraisingam, V. (2021). Drug Abuse Screening Test 10 (DAST-10): description, strengths and knowledge gaps. AOD Screening and Withdrawal Tools Collection. Adelaide, South Australia: NCETA, Flinders University.

Fischer, J. A., Roche, A. M., & Duraisingam, V. (2021). Drug Use Disorders Identification Test (DUDIT): description, strengths and knowledge gaps. AOD Screening and Withdrawal Tools Collection. Adelaide, South Australia: NCETA, Flinders University.

Fischer, J. A., Roche, A. M., & Duraisingam, V. (2021). Fagerstrom Test for Nicotine Dependence (FTND): description, strengths and knowledge gaps. AOD Screening and Withdrawal Tools Collection. Adelaide, South Australia: NCETA, Flinders University.

Fischer, J. A., Roche, A. M., & Duraisingam, V. (2021). Indigenous Risk Impact Screen (IRIS): description, strengths and knowledge gaps. AOD Screening and Withdrawal Tools Collection. Adelaide, South Australia: NCETA, Flinders University.

Fischer, J. A., Roche, A. M., & Duraisingam, V. (2021). Objective Opioid Withdrawal Scale (OOWS): description, strengths and knowledge gaps. AOD Screening and Withdrawal Tools Collection. Adelaide, South Australia: NCETA, Flinders University.

Fischer, J. A., Roche, A. M., & Duraisingam, V. (2021). Severity of Dependence Scale (SDS):  description, strengths and knowledge gaps. AOD Screening and Withdrawal Tools Collection. Adelaide, South Australia: NCETA, Flinders University.

Fischer, J. A., Roche, A. M., & Duraisingam, V. (2021). Subjective Opioid Withdrawal Scale (SOWS): description, strengths and knowledge gaps. AOD Screening and Withdrawal Tools Collection. Adelaide, South Australia: NCETA, Flinders University.